Orange Book product · Generic (ANDA)
LOW-OGESTREL-21
ETHINYL ESTRADIOL; NORGESTREL
At a glance
Jul 28, 1999
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 28, 1999
27 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
ETHINYL ESTRADIOL; NORGESTREL
Strength
0.03MG;0.3MG
Dosage form
TABLET
Route
ORAL-21
TE code
Not listed
Application
ANDA 075288
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETHINYL ESTRADIOL; NORGESTREL
- —LO/OVRALBrand (NDA)
NDA 017612 · CADENCE HEALTH
- —OVRALBrand (NDA)
NDA 016672 · WYETH PHARMS
- —LO/OVRAL-28Brand (NDA)
NDA 017802 · WYETH PHARMS
- —OVRAL-28Brand (NDA)
NDA 016806 · WYETH PHARMS
- 2023TURQOZGeneric (ANDA)
ANDA 202980 · LUPIN
- 2017NORGESTREL AND ETHINYL ESTRADIOLGeneric (ANDA)
ANDA 202875 · MYLAN LABS LTD
- 2016NORGESTREL AND ETHINYL ESTRADIOLGeneric (ANDA)
ANDA 201828 · MYLAN LABS LTD
- 2012ELINESTGeneric (ANDA)
ANDA 091105 · NOVAST LABS LTD
- 2001CRYSELLEGeneric (ANDA)
ANDA 075840 · DURAMED PHARMS BARR
- 1999OGESTREL 0.5/50-21Generic (ANDA)
ANDA 075406 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
